Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Showing 20 of 0 results

Not applicableStudy completedNCT01789138
What this trial is testing

Adherence Support Intervention for Persons Living With HIV/AIDS (PLWHA) on Antiretroviral Therapy (ART) in Estonia

Who this might be right for
HIVAIDSMedication Adherence
University of Tartu 519
Not applicableStudy completedNCT02405026
What this trial is testing

Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients

Who this might be right for
AsthmaHIV
Duke University 83
Testing effectiveness (Phase 2)Study completedNCT03819114
What this trial is testing

Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy

Who this might be right for
HIV InfectionsTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 122
Testing effectiveness (Phase 2)Ended earlyNCT01601626
What this trial is testing

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV

Who this might be right for
HIV InfectionTuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 71
Post-approval studies (Phase 4)Study completedNCT02180438
What this trial is testing

An Open Label Trial of Stribild for Antiretroviral (ARV)-naïve HIV-2 Infected Adults in Dakar, Senegal

Who this might be right for
HIV-2 Infection
University of Washington 30
Early research (Phase 1)Study completedNCT01227590
What this trial is testing

Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)

Who this might be right for
Drug InteractionsHuman Immunodeficiency Virus
University of California, San Francisco 18
Not applicableLooking for participantsNCT04667026
What this trial is testing

Observational Study on Patients With HIV/AIDS(OSPWH)

Who this might be right for
HIV Infections
Guangzhou 8th People's Hospital 15,000
Post-approval studies (Phase 4)Study completedNCT01989910
What this trial is testing

Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients

Who this might be right for
HIV-1 Infection
Taipei Veterans General Hospital, Taiwan 107
Not applicableStudy completedNCT02733003
What this trial is testing

Implementation Research for Vulnerable Women in South Africa

Who this might be right for
HIVSubstance Abuse
RTI International 564
Not applicableStudy completedNCT03385473
What this trial is testing

Individualized Antiretroviral Therapy

Who this might be right for
PharmacogeneticsHIVDrug Monitoring
Hospital Italiano de Buenos Aires 190
Not applicableEnded earlyNCT04024488
What this trial is testing

Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings

Who this might be right for
HIV-1-infection
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 484
Post-approval studies (Phase 4)Study completedNCT00735072
What this trial is testing

Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure

Who this might be right for
HIV Infection
University of California, San Francisco 45
Testing effectiveness (Phase 2)WithdrawnNCT05545319
What this trial is testing

Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Coronavirus Disease 2019 (COVID-19)Immunocompromised+2 more
Pfizer
Post-approval studies (Phase 4)Study completedNCT00444379
What this trial is testing

Anti-Retrovirals for Kaposi's Sarcoma

Who this might be right for
Kaposi's SarcomaHIV Infections
University of California, San Francisco 224
Testing effectiveness (Phase 2)Study completedNCT00078442
What this trial is testing

Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Not applicableStudy completedNCT00001131
What this trial is testing

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Testing effectiveness (Phase 2)Study completedNCT00007202
What this trial is testing

Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Testing effectiveness (Phase 2)Study completedNCT03262441
What this trial is testing

MMF for HIV Reservoir Reduction

Who this might be right for
Human Immunodeficiency Virus I Infection
Fred Hutchinson Cancer Center 5
Post-approval studies (Phase 4)Study completedNCT03160105
What this trial is testing

Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV)

Who this might be right for
HIV-1-infectionAntiretroviral TherapyMaintenance Therapy
Calmy Alexandra 186
Not applicableUnknownNCT05996094
What this trial is testing

Antiretroviral Adherence and Drug-level Monitoring

Who this might be right for
HIV InfectionsAIDSAntiretroviral Therapy, Highly Active+2 more
Zamrotul Izzah 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation